ArticleNPJ breast cancer2025

Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancer.

Akshara Singareeka Raghavendra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.